One patient, one hope: Custom-Made immune cells battle rare cancer
NCT ID NCT06789081
Summary
This is a single-patient study for someone with advanced alveolar soft part sarcoma, a rare cancer, that has progressed despite other treatments. The study will test a personalized therapy called GCAR1, which involves modifying the patient's own immune cells to attack their cancer. The main goal is to see if this experimental treatment can shrink the patient's tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALVEOLAR SOFT PART SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.